/PRNewswire/ The "Global Cancer Biomarkers Market by Type (Protein, Genetic), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Profiling Technology.
According to Precedence Research, the global cancer biomarkers market size is projected to surpass around US$ 32.09 billion by 2030 and it is expanding at.
The "Global Cancer Biomarkers Market by Type (Protein, Genetic), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application
A recent Federal Circuit decision vacating a $137 million patent verdict against Roche underscores the hurdles to proving induced infringement, namely by stressing it is closely tied to willful infringement and requires an element of intent to cause others to infringe.
The US Court of Appeals for the Federal Circuit vacated a damages verdict because the acts supporting the induced infringement finding took place years before the statutory damages.